Motley Fool: Oncolytics – Cancer Killing Virus enters Phase II Metastatic Melanoma Trial

A unique drug is on the right pathway to success, as Oncolytics Biotechnology (ONCY) is pushing Reolysin through the pipeline. David Williamson from Motley Fool reported that this cancer medication is based off a common virus, incidentally referred to as the new “Cancer-Killing Virus.”

Read more »